Empagliflozin CAS: 864070-44-0 Mai samarwa

Empagliflozin wani labari ne, mai ƙarfi kuma mai zaɓin SGLT-2 mai hanawa, yana haɓaka sarrafa glycemic da fasali na cututtukan rayuwa a cikin berayen masu ciwon sukari. yana haifar da ciwon sukari a cikin jini don fitar da koda kuma a kawar da shi a cikin fitsari.Empagliflozin na iya haifar da bushewa kuma ya haifar da raguwar hawan jini, yana haifar da masu fama da juwa ko suma da raguwar aikin koda.Haɗarin tsofaffin marasa lafiya, musamman waɗanda ke da ƙarancin aikin koda da diuretics, sun bayyana sun fi girma.FDA na buƙatar Boehring da Eli Lilly don gudanar da karatun bayan tallace-tallace guda huɗu: kammala gwajin sakamakon sakamako na zuciya da jijiyoyin jini, pharmacokinetics na pediatric da pharmacodynamics gwaji, lafiyar yara da inganci. gwaje-gwaje, gwajin guba na miyagun ƙwayoyi (musamman tasiri ga aikin koda, kashi da girma da ci gaba).